icon-folder.gif   Conference Reports for NATAP  
 
 

16thEuro

Back grey_arrow_rt.gif
 
 
 
High SVR 12 rates with grazoprevir/elbasvir ± ribavirin for 12-16 weeks guided by genotypic resistance testing among HIV/HCV coinfected MSM in the Swiss HCVree Trial
 
 
  Reported by Jules Levin
16th European AIDS Conference, October 25-27, 2017. Milan
 
Dominique L. Braun1,2, Benjamin Hampel1,2, Roger Kouyos1, Jürg Böni2, Markus Flepp3, Marcel Stöckle4, Anna Conen5, Charles Béguelin6, Dunja Nicca7, Patrick Schmid8, Julie Delaloye9, Mathieu Rougemont10, Enos Bernasconi11, Huldrych F. Günthard1,Jan Fehr1, and the Swiss HIV Cohort Study

1030171

1030172

1030173

1030174

1030175

1030176

1030177

1030178